Variant report
Variant | rs11211215 |
---|---|
Chromosome Location | chr1:46347813-46347814 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:46346412..46348926-chr1:46358537..46360878,2 | K562 | blood: | |
2 | chr1:46345992..46348458-chr1:46350883..46353705,2 | K562 | blood: | |
3 | chr1:46341326..46343341-chr1:46347257..46349612,2 | K562 | blood: | |
4 | chr1:46152211..46153942-chr1:46345305..46348053,3 | K562 | blood: | |
5 | chr1:46320162..46320843-chr1:46346948..46347886,2 | MCF-7 | breast: | |
6 | chr1:46347506..46350067-chr16:85637781..85639346,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000159596 | Chromatin interaction |
ENSG00000159592 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs10127690 | 0.84[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs10158032 | 0.88[AFR][1000 genomes];0.95[AMR][1000 genomes];0.93[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs10437063 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs10732844 | 0.86[AFR][1000 genomes];0.80[AMR][1000 genomes];0.92[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs10749858 | 0.87[AMR][1000 genomes];0.92[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs10789475 | 0.86[ASN][1000 genomes] |
rs10789478 | 0.83[AMR][1000 genomes];0.94[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10789479 | 0.83[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10789484 | 0.80[AMR][1000 genomes];0.87[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10789485 | 0.88[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10789486 | 0.80[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10890350 | 0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs10890353 | 0.95[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs10890355 | 0.86[AFR][1000 genomes];0.98[AMR][1000 genomes];0.92[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10890358 | 0.94[AMR][1000 genomes];0.94[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs10890359 | 0.96[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs10890360 | 0.88[AFR][1000 genomes];0.98[AMR][1000 genomes];0.94[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs10890365 | 0.86[AFR][1000 genomes];0.92[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs10890370 | 0.90[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10890371 | 0.81[AFR][1000 genomes];0.80[AMR][1000 genomes];0.91[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10890372 | 0.83[AFR][1000 genomes];0.80[AMR][1000 genomes];0.91[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10890373 | 0.91[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10890374 | 0.80[AMR][1000 genomes];0.87[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10890376 | 0.87[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs10890377 | 0.87[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs10890378 | 0.80[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs10890380 | 0.86[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs10890381 | 0.86[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs10890382 | 0.84[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs11211182 | 0.82[ASN][1000 genomes] |
rs11211190 | 0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs11211194 | 0.89[AMR][1000 genomes];0.91[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs11211200 | 0.83[AFR][1000 genomes];0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs11211202 | 0.84[AFR][1000 genomes];0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs11211204 | 0.83[AFR][1000 genomes];0.98[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs11211205 | 0.86[AFR][1000 genomes];0.98[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs11211209 | 0.86[AMR][1000 genomes];0.94[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs11211217 | 0.91[AFR][1000 genomes];0.98[AMR][1000 genomes];0.95[EUR][1000 genomes];0.95[ASN][1000 genomes] |
rs11211218 | 0.86[AFR][1000 genomes];0.94[AMR][1000 genomes];0.92[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs11211219 | 0.86[AFR][1000 genomes];0.92[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs11211222 | 0.86[AFR][1000 genomes];0.80[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs11211223 | 0.90[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs11211228 | 0.80[AMR][1000 genomes];0.90[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs11211229 | 0.80[AMR][1000 genomes];0.90[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs11211232 | 0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs11211235 | 0.87[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs11211236 | 0.87[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs11211237 | 0.86[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs11211238 | 0.86[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs11211239 | 0.85[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs11211244 | 0.85[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs11211248 | 0.84[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs12022335 | 0.88[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12029972 | 0.84[ASN][1000 genomes] |
rs12060274 | 0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12067716 | 0.87[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs12076580 | 0.87[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs12077546 | 0.87[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs12077916 | 0.86[AMR][1000 genomes];0.89[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs12077974 | 0.88[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs12094860 | 0.83[AFR][1000 genomes];0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12094901 | 0.92[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12097761 | 0.83[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12097799 | 0.84[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs12124291 | 0.87[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs12124847 | 0.91[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs12131529 | 0.80[AMR][1000 genomes];0.91[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12133129 | 0.86[AFR][1000 genomes];0.80[AMR][1000 genomes];0.92[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs12145287 | 0.86[AMR][1000 genomes];0.93[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs12403666 | 0.87[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs12565042 | 0.85[ASN][1000 genomes] |
rs28636523 | 0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs28831083 | 0.86[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs34444543 | 0.86[AFR][1000 genomes];0.94[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs34446427 | 0.80[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs34694458 | 0.92[AMR][1000 genomes];0.94[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs35018217 | 0.86[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs3922886 | 0.84[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs3922887 | 0.84[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4073847 | 0.84[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4074225 | 0.91[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4134387 | 0.91[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4275489 | 0.82[ASN][1000 genomes] |
rs4297233 | 0.83[AFR][1000 genomes];0.91[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs4298677 | 0.95[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs4390216 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4454479 | 0.80[AMR][1000 genomes];0.88[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4459051 | 0.86[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4460583 | 0.86[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4489497 | 0.87[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs4508055 | 0.87[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs4524994 | 0.86[AFR][1000 genomes];0.80[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs4539075 | 0.86[AFR][1000 genomes];0.94[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs4553121 | 0.86[AFR][1000 genomes];0.92[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs4606257 | 0.88[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs4607936 | 0.82[ASN][1000 genomes] |
rs4630155 | 0.87[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs4641257 | 0.86[AFR][1000 genomes];0.94[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs4660318 | 0.90[AFR][1000 genomes];0.98[AMR][1000 genomes];0.94[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs4660328 | 0.87[EUR][1000 genomes] |
rs4660331 | 0.85[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs4660332 | 0.85[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4660334 | 0.85[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs4660335 | 0.84[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4660336 | 0.82[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs4660889 | 0.85[AFR][1000 genomes];0.95[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs4660895 | 0.90[AFR][1000 genomes];0.98[AMR][1000 genomes];0.94[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs4660896 | 0.86[AFR][1000 genomes];0.80[AMR][1000 genomes];0.92[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs4660900 | 0.80[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4660903 | 0.85[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4660904 | 0.85[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4660905 | 0.85[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4660906 | 0.84[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs4994390 | 0.88[AMR][1000 genomes];0.93[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs61785584 | 0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs61785613 | 0.87[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs61785614 | 0.86[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs6429580 | 0.87[AMR][1000 genomes];0.91[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs6429581 | 0.87[AMR][1000 genomes];0.93[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6429588 | 0.85[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs6657720 | 0.83[AFR][1000 genomes];0.80[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6661500 | 0.84[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs6666743 | 0.87[ASN][1000 genomes] |
rs6666763 | 0.86[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs6671754 | 0.86[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs6672115 | 0.91[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs6674794 | 0.85[AMR][1000 genomes];0.92[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs6675222 | 0.88[AFR][1000 genomes];0.98[AMR][1000 genomes];0.92[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs6676982 | 0.88[AMR][1000 genomes];0.91[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs6677777 | 0.84[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs6680211 | 0.87[ASN][1000 genomes] |
rs6681068 | 0.82[AFR][1000 genomes];0.80[AMR][1000 genomes];0.91[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6682683 | 0.91[AFR][1000 genomes];0.98[AMR][1000 genomes];0.94[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs6687301 | 0.83[AFR][1000 genomes];0.80[AMR][1000 genomes];0.91[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs6690386 | 0.87[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs6690652 | 0.85[AFR][1000 genomes];0.80[AMR][1000 genomes];0.90[EUR][1000 genomes];0.91[ASN][1000 genomes] |
rs6690775 | 0.87[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs6693336 | 0.86[AFR][1000 genomes];0.94[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs6694340 | 0.86[ASN][1000 genomes] |
rs6695421 | 0.85[AFR][1000 genomes];0.80[AMR][1000 genomes];0.90[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs6697830 | 0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs6701694 | 0.91[AMR][1000 genomes];0.90[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs7512395 | 0.91[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs7515491 | 0.90[ASN][1000 genomes] |
rs7517560 | 0.80[AMR][1000 genomes];0.87[EUR][1000 genomes];0.89[ASN][1000 genomes] |
rs7519181 | 0.83[AFR][1000 genomes];0.90[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs7526369 | 0.83[AFR][1000 genomes];0.80[AMR][1000 genomes];0.91[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs7526532 | 0.86[ASN][1000 genomes] |
rs7527079 | 0.80[AMR][1000 genomes];0.89[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs7527244 | 0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs7527298 | 0.80[AMR][1000 genomes];0.87[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs7531911 | 0.96[AMR][1000 genomes];0.94[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs7532204 | 0.83[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs7534331 | 0.82[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs7539800 | 0.91[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs7546237 | 0.91[AMR][1000 genomes];0.91[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs7547189 | 0.85[AFR][1000 genomes];0.98[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs7547284 | 0.86[AFR][1000 genomes];0.96[AMR][1000 genomes];0.94[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs7551025 | 0.87[AMR][1000 genomes];0.90[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs7553924 | 0.86[AFR][1000 genomes];0.94[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs785478 | 0.83[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs785480 | 0.83[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs946524 | 0.83[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs946525 | 0.83[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs946527 | 0.80[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs946528 | 0.85[ASN][1000 genomes] |
rs9787208 | 0.87[ASN][1000 genomes] |
rs9787412 | 0.86[AFR][1000 genomes];0.80[AMR][1000 genomes];0.92[EUR][1000 genomes];0.92[ASN][1000 genomes] |
rs9793167 | 0.86[EUR][1000 genomes];0.86[ASN][1000 genomes] |
rs9803784 | 0.80[AMR][1000 genomes];0.90[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs9919275 | 0.84[EUR][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv932680 | chr1:45935520-46686477 | Strong transcription Weak transcription Flanking Active TSS Active TSS Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 232 gene(s) | inside rSNPs | diseases |
2 | nsv868828 | chr1:45953923-46686477 | Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 232 gene(s) | inside rSNPs | diseases |
3 | nsv871928 | chr1:46024701-46609736 | Weak transcription Enhancers ZNF genes & repeats Strong transcription Active TSS Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 123 gene(s) | inside rSNPs | diseases |
4 | nsv1014128 | chr1:46097670-46394540 | Weak transcription Flanking Active TSS Strong transcription Active TSS Enhancers Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 77 gene(s) | inside rSNPs | diseases |
5 | nsv1006861 | chr1:46144479-46417621 | Weak transcription Enhancers ZNF genes & repeats Strong transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 76 gene(s) | inside rSNPs | diseases |
6 | nsv1003049 | chr1:46144479-46476149 | Enhancers Weak transcription Active TSS Flanking Active TSS Strong transcription ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 78 gene(s) | inside rSNPs | diseases |
7 | nsv1008219 | chr1:46160098-46493958 | Genic enhancers Strong transcription ZNF genes & repeats Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 42 gene(s) | inside rSNPs | diseases |
8 | nsv534943 | chr1:46160098-46493958 | Enhancers Flanking Active TSS Strong transcription Weak transcription Bivalent Enhancer Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 42 gene(s) | inside rSNPs | diseases |
9 | nsv1000498 | chr1:46171836-46438252 | Weak transcription ZNF genes & repeats Enhancers Strong transcription Active TSS Flanking Active TSS Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
10 | nsv870791 | chr1:46182916-46398415 | Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 38 gene(s) | inside rSNPs | diseases |
11 | nsv998925 | chr1:46184925-46353041 | Weak transcription Flanking Active TSS Enhancers Strong transcription Active TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 37 gene(s) | inside rSNPs | diseases |
12 | nsv1003986 | chr1:46184925-46417621 | Active TSS Weak transcription Enhancers Flanking Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
13 | nsv1007501 | chr1:46184925-46439533 | Enhancers Weak transcription Strong transcription Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS ZNF genes & repeats Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
14 | nsv534944 | chr1:46184925-46439533 | Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
15 | nsv1006891 | chr1:46189258-46408032 | Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription Transcr. at gene 5' and 3' Genic enhancers Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 38 gene(s) | inside rSNPs | diseases |
16 | nsv1009355 | chr1:46189258-46463012 | Active TSS Genic enhancers ZNF genes & repeats Enhancers Flanking Active TSS Strong transcription Weak transcription Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 39 gene(s) | inside rSNPs | diseases |
17 | nsv871312 | chr1:46196813-46353332 | Enhancers Active TSS Flanking Active TSS Weak transcription Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 37 gene(s) | inside rSNPs | diseases |
18 | nsv546158 | chr1:46216575-46495434 | Flanking Active TSS Weak transcription Active TSS Enhancers Strong transcription Bivalent Enhancer Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 30 gene(s) | inside rSNPs | diseases |
19 | nsv870911 | chr1:46216575-46498375 | Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS Strong transcription ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 32 gene(s) | inside rSNPs | diseases |
20 | nsv1013628 | chr1:46221617-46356565 | Enhancers Flanking Active TSS Strong transcription Weak transcription Active TSS ZNF genes & repeats Bivalent Enhancer Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 12 gene(s) | inside rSNPs | diseases |
21 | nsv431268 | chr1:46223080-46495480 | Strong transcription Enhancers Weak transcription Flanking Active TSS Genic enhancers ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 17 gene(s) | inside rSNPs | diseases |
22 | nsv546159 | chr1:46223086-46398415 | Enhancers Strong transcription Genic enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
23 | nsv461417 | chr1:46223086-46416348 | Weak transcription Active TSS Flanking Active TSS Enhancers Strong transcription ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
24 | nsv546160 | chr1:46223086-46416348 | ZNF genes & repeats Enhancers Weak transcription Flanking Active TSS Strong transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
25 | nsv524147 | chr1:46236098-46438076 | Weak transcription Active TSS Enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
26 | nsv1007162 | chr1:46244432-46417621 | Enhancers Weak transcription Strong transcription Flanking Active TSS Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
27 | nsv1015136 | chr1:46244432-46439533 | Enhancers Weak transcription Flanking Active TSS Active TSS Strong transcription Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
28 | nsv1003517 | chr1:46244432-46609881 | Enhancers Weak transcription Strong transcription Active TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 39 gene(s) | inside rSNPs | diseases |
29 | nsv1007759 | chr1:46248667-46493959 | Enhancers Weak transcription Strong transcription Active TSS Genic enhancers ZNF genes & repeats Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
30 | nsv534945 | chr1:46248667-46493959 | Weak transcription Strong transcription ZNF genes & repeats Enhancers Genic enhancers Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
31 | nsv916232 | chr1:46248686-46493918 | Genic enhancers Active TSS Flanking Active TSS Enhancers Weak transcription Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
32 | nsv437479 | chr1:46272879-46411146 | Strong transcription Flanking Active TSS Weak transcription Enhancers Active TSS ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 9 gene(s) | inside rSNPs | diseases |
33 | nsv1013729 | chr1:46286329-46363880 | Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Strong transcription Genic enhancers | TF binding regionChromatin interactive region | 7 gene(s) | inside rSNPs | diseases |
34 | nsv1009527 | chr1:46286329-46520127 | Weak transcription Genic enhancers Strong transcription Flanking Active TSS Enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
35 | nsv546161 | chr1:46311275-46498375 | Weak transcription Flanking Active TSS Enhancers Strong transcription ZNF genes & repeats Active TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 14 gene(s) | inside rSNPs | diseases |
36 | nsv1009474 | chr1:46320433-46557734 | Weak transcription Flanking Active TSS Enhancers Strong transcription Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
37 | nsv1003554 | chr1:46331254-46410657 | Enhancers Flanking Active TSS Weak transcription Active TSS Strong transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 7 gene(s) | inside rSNPs | diseases |
38 | nsv1005189 | chr1:46335186-46949309 | Bivalent/Poised TSS Weak transcription Active TSS Bivalent Enhancer Strong transcription Flanking Active TSS Enhancers Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 72 gene(s) | inside rSNPs | diseases |
39 | nsv534946 | chr1:46335186-46949309 | ZNF genes & repeats Strong transcription Flanking Active TSS Weak transcription Enhancers Genic enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 72 gene(s) | inside rSNPs | diseases |
40 | esv2761743 | chr1:46339858-47026743 | Active TSS Weak transcription Bivalent Enhancer Enhancers Strong transcription Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 80 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:46330200-46353200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr1:46330200-46357600 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
3 | chr1:46332200-46357400 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
4 | chr1:46333400-46348200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr1:46333800-46357400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
6 | chr1:46336600-46356800 | Weak transcription | Small Intestine | intestine |
7 | chr1:46336600-46357600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr1:46337600-46350400 | Weak transcription | Fetal Lung | lung |
9 | chr1:46337800-46356000 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
10 | chr1:46338000-46350400 | Weak transcription | HSMM | muscle |
11 | chr1:46338000-46357400 | Weak transcription | Hela-S3 | cervix |
12 | chr1:46338400-46350000 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
13 | chr1:46338400-46353000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr1:46338400-46357600 | Weak transcription | Fetal Intestine Large | intestine |
15 | chr1:46339000-46348000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr1:46339200-46355000 | Weak transcription | Fetal Intestine Small | intestine |
17 | chr1:46342000-46350400 | Weak transcription | K562 | blood |
18 | chr1:46342200-46357000 | Weak transcription | HUVEC | blood vessel |
19 | chr1:46342200-46391200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
20 | chr1:46342600-46350400 | Weak transcription | Aorta | Aorta |
21 | chr1:46343200-46348000 | Weak transcription | HepG2 | liver |
22 | chr1:46343200-46352400 | Weak transcription | Psoas Muscle | Psoas |
23 | chr1:46346200-46348600 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
24 | chr1:46346200-46349400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
25 | chr1:46346200-46349800 | Weak transcription | A549 | lung |
26 | chr1:46346400-46357000 | Weak transcription | Left Ventricle | heart |
27 | chr1:46347200-46348000 | Weak transcription | HSMMtube | muscle |
28 | chr1:46347200-46357400 | Weak transcription | Muscle Satellite Cultured Cells | -- |
29 | chr1:46347400-46348200 | Weak transcription | Fetal Muscle Leg | muscle |
30 | chr1:46347400-46349000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
31 | chr1:46347400-46349600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
32 | chr1:46347400-46353000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
33 | chr1:46347400-46357200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
34 | chr1:46347400-46357400 | Weak transcription | NH-A | brain |
35 | chr1:46347400-46357400 | Weak transcription | NHDF-Ad | bronchial |
36 | chr1:46347400-46378400 | Weak transcription | Brain Germinal Matrix | brain |
37 | chr1:46347600-46349000 | Weak transcription | Osteobl | bone |